Improvement in Quality of Life and Pain Scores After Laparoscopic Management of Deep Infiltrating Endometriosis

NCT04062916 | Completed

• 1 other identifier: AcibademFulyaHendo
• Study Type: observational
• Target: 65
• Locations: 1 country
• Sites: 1

Brief Summary

This is a retrospective cohort study that evaluates the postoperative pain findings of a consecutive series of laparoscopic surgeries for deep infiltrating endometriosis (DIE).

Conditions

Endometriosis

Keywords

endometriosis

Outcome Measures

Primary Outcomes (2)

• Quality of Life after endometriosis surgery

  Effects of endometriosis surgery on the quality of life by using BSGE pelvic pain questionnaire

  7 years

• Pain levels after endometriosis surgery

  Effects of endometriosis surgery on pelvic pain by using VAS scores

  3 years

Study Arms (1)

women with endometriosis

65 women whose main symptom was pain and who did not respond to medical treatment and underwent endometriosis surgery

Other: BSGE pelvic pain questionnaire and VAS scores

Interventions

BSGE pelvic pain questionnaire and VAS scores OTHER

Patients were evaluated using the BSGE pelvic pain questionnaire in terms of pre-operative and post-operative pain assessment in order to determine the effects of endometriosis surgery on the quality of life. The patients were asked to indicate their levels of dyspareunia, dysmenorrhea, and chronic pelvic pain on a VAS on the pelvic pain questionnaire.

women with endometriosis

Eligibility Criteria

• Age: 22 Years - 50 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Women with endometriosis 65 women whose main symptom was pain and who did not respond to medical treatment and underwent endometriosis surgery

You may qualify if:

• Patients with deep infiltration endometriosis and endometrioma diagnosed through bimanual gynecologic examination, gynecologic ultrasound or through laparoscopically confirmed endometrioma and DIE together;
• DIE with bowel involvement that required shaving or segmental resection for colorectal lesions and nodules;
• Who completed the VAS score and BSGE questionnaire;
• Follow-up period of at least 3 months;
• Patients resistant to medical therapy (NSAIDs, OCPs, levonorgestrel-releasing intrauterine device (IUD), and progesterone) or refuse to use medical therapy.

Sponsors & Collaborators

• Acibadem Fulya Hastanesi: lead

Study Sites (1)

Acibadem Fulya Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, Female; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Genital Diseases

Study Officials

• Ercan Bastu, MSc, MD

  Acibadem Fulya Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: NETWORK
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 16, 2019
• First Posted: August 20, 2019
• Study Start: January 1, 2013
• Primary Completion: May 1, 2019
• Study Completion: June 1, 2019
• Last Updated: August 20, 2019

Record last verified: 2019-08

Locations

TU (1)